JP2019510025A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019510025A5 JP2019510025A5 JP2018549444A JP2018549444A JP2019510025A5 JP 2019510025 A5 JP2019510025 A5 JP 2019510025A5 JP 2018549444 A JP2018549444 A JP 2018549444A JP 2018549444 A JP2018549444 A JP 2018549444A JP 2019510025 A5 JP2019510025 A5 JP 2019510025A5
- Authority
- JP
- Japan
- Prior art keywords
- acceptable salt
- compound
- pharmaceutically acceptable
- hydrogen
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662313334P | 2016-03-25 | 2016-03-25 | |
| US62/313,334 | 2016-03-25 | ||
| PCT/US2017/023126 WO2017165255A1 (en) | 2016-03-25 | 2017-03-20 | Pyrimidines and variants thereof, and uses therefor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019510025A JP2019510025A (ja) | 2019-04-11 |
| JP2019510025A5 true JP2019510025A5 (cg-RX-API-DMAC7.html) | 2020-04-09 |
| JP6902045B2 JP6902045B2 (ja) | 2021-07-14 |
Family
ID=59900805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018549444A Active JP6902045B2 (ja) | 2016-03-25 | 2017-03-20 | ピリミジンおよびそのバリアント、ならびにそのための使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10662162B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3433258B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6902045B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102377805B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108779119B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017237929B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3018180C (cg-RX-API-DMAC7.html) |
| MA (1) | MA44489A (cg-RX-API-DMAC7.html) |
| MX (1) | MX384368B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2760733C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017165255A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10822311B2 (en) | 2016-03-14 | 2020-11-03 | Afferent Pharmaceuticals, Inc. | Pyrimidines and variants thereof, and uses therefor |
| KR102377805B1 (ko) | 2016-03-25 | 2022-03-22 | 애퍼런트 파마슈티컬스 인크. | 피리미딘 및 그의 변이체, 및 그의 용도 |
| AU2017381739B2 (en) | 2016-12-19 | 2020-06-11 | Novartis Ag | New picolinic acid derivatives and their use as intermediates |
| US10676444B2 (en) * | 2016-12-20 | 2020-06-09 | Afferent Pharmaceuticals, Inc. | Crystalline salts and polymorphs of a P2X3 antagonist |
| US11414444B2 (en) | 2017-11-01 | 2022-08-16 | Beijing Tide Pharmaceutical Co., Ltd. | P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof |
| CN107778255B (zh) * | 2017-11-16 | 2019-10-25 | 山东大学 | 一种二芳基嘧啶类hiv-1逆转录酶抑制剂及其制备方法和应用 |
| KR20220008286A (ko) * | 2019-04-30 | 2022-01-20 | 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 | 디아미노피리미딘 화합물을 사용하여 자궁내막증-관련 통증 치료 방법 |
| WO2020221275A1 (zh) * | 2019-04-30 | 2020-11-05 | 北京泰德制药股份有限公司 | 二氨基嘧啶类化合物或其水合物的固体形式及其制备方法和用途 |
| US20220211703A1 (en) * | 2019-04-30 | 2022-07-07 | Beijing Tide Pharmaceutical Co., Ltd. | Method for treating cough by using diaminopyrimidine compound |
| EP3981765A4 (en) * | 2019-06-06 | 2023-05-31 | Beijing Tide Pharmaceutical Co., Ltd. | P2X3 AND/OR P2X2/3 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION CONTAINING IT AND THEIR USE |
| CN120058573B (zh) * | 2025-04-29 | 2025-12-23 | 潍坊学院 | 一种1-三溴甲基磺酰基萘及其衍生物的合成方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2953567A (en) * | 1956-11-23 | 1960-09-20 | Burroughs Wellcome Co | 5-phenylmercaptopyrimidines and method |
| WO2000059893A1 (en) * | 1999-04-06 | 2000-10-12 | Krenitsky Pharmaceuticals Inc. | Neurotrophic thio substituted pyrimidines |
| EP1345926B1 (en) | 2000-12-21 | 2006-05-17 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| AU2005229331B2 (en) * | 2004-03-05 | 2011-10-13 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as P2X3 and P2X2/3 antagonists |
| WO2007025899A1 (en) * | 2005-09-01 | 2007-03-08 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| EP1924566B1 (en) * | 2005-09-01 | 2016-01-13 | F.Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| BRPI0615040A2 (pt) * | 2005-09-01 | 2011-04-26 | Hoffmann La Roche | diaminopirimidinas como moduladores de p2x3 e p2x2/3 |
| EP1924565B1 (en) * | 2005-09-01 | 2016-09-14 | F.Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p3x2/3 modulators |
| EP2079713B1 (en) * | 2006-10-04 | 2014-04-16 | F. Hoffmann-La Roche AG | Process for synthesis of phenoxy diaminopyrimidine derivatives |
| WO2008104474A1 (en) * | 2007-02-28 | 2008-09-04 | F. Hoffmann-La Roche Ag | Diaminopyrimidines |
| WO2008104472A1 (en) | 2007-02-28 | 2008-09-04 | F. Hoffmann-La Roche Ag | 2, 4 -diaminopyrimidine derivatives and their use as p2x antagonists or as prodrugs thereof |
| AU2008319735A1 (en) * | 2007-10-31 | 2009-05-07 | Nissan Chemical Industries, Ltd. | Pyridazinone derivatives and use thereof as P2X7 receptor inhibitors |
| GB2471713A (en) | 2009-07-08 | 2011-01-12 | Univ Greenwich | 1,2,4-triazine derivatives and their use as sodium channel blockers |
| TWI637949B (zh) * | 2013-06-14 | 2018-10-11 | 塩野義製藥股份有限公司 | 胺基三衍生物及含有其等之醫藥組合物 |
| NZ716977A (en) * | 2013-08-23 | 2017-09-29 | Afferent Pharmaceuticals Inc | Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of acute and sub-acute cough, urge to cough and chronic cough, in respiratory diseases |
| EP3981406A1 (en) * | 2014-07-03 | 2022-04-13 | Afferent Pharmaceuticals Inc. | Methods and compositions for treating diseases and conditions |
| US10822311B2 (en) * | 2016-03-14 | 2020-11-03 | Afferent Pharmaceuticals, Inc. | Pyrimidines and variants thereof, and uses therefor |
| KR102377805B1 (ko) * | 2016-03-25 | 2022-03-22 | 애퍼런트 파마슈티컬스 인크. | 피리미딘 및 그의 변이체, 및 그의 용도 |
-
2017
- 2017-03-20 KR KR1020187029805A patent/KR102377805B1/ko active Active
- 2017-03-20 RU RU2018137032A patent/RU2760733C2/ru active
- 2017-03-20 CN CN201780019534.0A patent/CN108779119B/zh active Active
- 2017-03-20 AU AU2017237929A patent/AU2017237929B2/en active Active
- 2017-03-20 EP EP17770880.7A patent/EP3433258B1/en active Active
- 2017-03-20 US US16/080,840 patent/US10662162B2/en active Active
- 2017-03-20 MA MA044489A patent/MA44489A/fr unknown
- 2017-03-20 WO PCT/US2017/023126 patent/WO2017165255A1/en not_active Ceased
- 2017-03-20 MX MX2018011622A patent/MX384368B/es unknown
- 2017-03-20 CA CA3018180A patent/CA3018180C/en active Active
- 2017-03-20 JP JP2018549444A patent/JP6902045B2/ja active Active
-
2020
- 2020-04-13 US US16/846,452 patent/US11230532B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019510025A5 (cg-RX-API-DMAC7.html) | ||
| MX2018009840A (es) | Sulfonilureas y compuestos relacionados y sus usos. | |
| JP2017509586A5 (cg-RX-API-DMAC7.html) | ||
| RU2018137032A (ru) | Пиримидины и их варианты, и их применение | |
| JP2015517981A5 (cg-RX-API-DMAC7.html) | ||
| JOP20200194A1 (ar) | صور بلورية جديدة | |
| JP2009532486A5 (cg-RX-API-DMAC7.html) | ||
| JP2006515858A5 (cg-RX-API-DMAC7.html) | ||
| JP2017533968A5 (cg-RX-API-DMAC7.html) | ||
| JP2011219498A5 (cg-RX-API-DMAC7.html) | ||
| JP2012140432A5 (cg-RX-API-DMAC7.html) | ||
| HRP20170638T1 (hr) | MODULATORI RETINOIDNIMA SRODNOG SIROČETA RECEPTORA γ (ROR-γ), NAMIJENJENI UPOTREBI U LIJEČENJU AUTOIMUNIH I PROTUUPALNIH BOLESTI | |
| HRP20211041T1 (hr) | Anthelmintski depsipeptidni spojevi | |
| JP2016534134A5 (cg-RX-API-DMAC7.html) | ||
| JP2013505903A5 (cg-RX-API-DMAC7.html) | ||
| EA201690019A1 (ru) | Производное аминотриазина и содержащая его фармацевтическая композиция | |
| JP2016515131A5 (cg-RX-API-DMAC7.html) | ||
| JO2644B1 (en) | Derivatives of N- (amino-aryl mixture) -H1- indole-2-carboxamide Synthesis and therapeutic use | |
| JP2016505637A5 (cg-RX-API-DMAC7.html) | ||
| JP2016530213A5 (cg-RX-API-DMAC7.html) | ||
| JP2019501130A5 (cg-RX-API-DMAC7.html) | ||
| JP2011526913A5 (ja) | キナゾリン化合物及び同化合物を含む治療薬 | |
| JP2018527301A5 (ja) | アジリジン含有ｄｎａアルキル化剤 | |
| BR112017004673A2 (pt) | formas cristalinas de 2-(4-(4-etoxi-6-oxo-1,6-diidropiridin-3-ila)-2-fluorofenil)-n-(5-(1,1,1-trifluoro-2-metilpropan-2-il)isoxazol-3-il) acetamida | |
| HUE058196T2 (hu) | N-{4-[(6,7-dimetoxikinolin-4-il)oxi]fenil}-N'-(4-fluorfenil)ciklopropán-1,1-dikarboxamid kristályos szilárd sói, elõállítási eljárások és alkalmazási eljárások |